APA

Krzeski P., Buckland-Wright C., Bálint G., Cline G. A., Stoner K., Lyon R., Beary J., Aronstein W. S. & Spector T. D. (20080408). Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. : Arthritis research & therapy.

Chicago

Krzeski Piotr, Buckland-Wright Chris, Bálint Géza, Cline Gary A, Stoner Karen, Lyon Robert, Beary John, Aronstein William S and Spector Tim D. 20080408. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. : Arthritis research & therapy.

Harvard

Krzeski P., Buckland-Wright C., Bálint G., Cline G. A., Stoner K., Lyon R., Beary J., Aronstein W. S. and Spector T. D. (20080408). Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. : Arthritis research & therapy.

MLA

Krzeski Piotr, Buckland-Wright Chris, Bálint Géza, Cline Gary A, Stoner Karen, Lyon Robert, Beary John, Aronstein William S and Spector Tim D. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. : Arthritis research & therapy. 20080408.